Fulcrum Therapeutics Inc (FULC)

Stock-Based Compensation

$13.56M

TTM · Period ending: · USD

FULC logo

FULC Stock-Based Compensation

Latest reported$13.56M
FULC Stock-Based Comp ($1.37M → $13.56M)
High-resolution chart · PNG

FULC stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Fulcrum Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
12,468,000
14,554,000
14,802,000
13,350,000
11,070,000
7,350,000
4,224,000
2,159,000
1,371,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.